#1
|
|||
|
|||
Êñàëàòàí ïðè áëèçîðóêîñòè
Ó ìîåãî ñûíà (12 ëåò) ìèîïèÿ ñëàáîé ñòåïåíè (-2,5). Çà ïîñëåäíèé ãîä çðåíèå óïàëî íà 1 äï. Â ýòî âðåìÿ áûëî ïðîâåäåíî 3 êóðñà èãëîóêàëûâàíèÿ, ýëåêòðîñòèìóëÿöèè, äåíîñ, ìàãíèò, ôîòîòåðàïèÿ, ìàññàæ.
Äî òîãî ïîëòîðà ãîäà ðàçìåð áëèçîðóêîñòè íå óâåëè÷èâàëñÿ. Ñåé÷àñ íàì ïðåäëîæèëè íà âûáîð - ëèáî ñêëåðîïëàñòèêó, ëèáî ñíèæàòü âíóòðèãëàçíîå äàâëåíèå (ñåé÷àñ îíî è òàê â íîðìå) êàïëÿìè Êñàëàòàí â íàäåæäå, ÷òî ýòî ïðèîñòàíîâèò ðîñò áëèçîðóêîñòè. Âðà÷ ïðåäóïðåäèëà íàñ, ÷òî ýòî íàçíà÷åíèå - íå ñîâñåì îôèöèàëüíîå, ò.ê. ýòè êàïëè íå ïðåäíàçíà÷åíû äëÿ äåòåé. Ïîïûòàëàñü íàéòè â ñåòè îòçûâû òåõ, êîìó òàêîå óæå íàçíà÷àëè, - è íå ñìîãëà. Äåéñòâèòåëüíî ëè ïîíèæåíèå (íîðìàëüíîãî) âíóòðèãëàçíîãî äàâëåíèÿ ìîæåò ïðèòîðìîçèòü ðàçâèòèå áëèçîðóêîñòè? Åñòü ëè êàêèå-òî èññëåäîâàíèÿ íà ýòó òåìó? Èçâåñòíà ëè ýôôåêòèâíîñòü ýòîãî ìåòîäà? |
#2
|
|||
|
|||
ïðîñòèòå, íî ýòî - àóò! è ëå÷åíèå âîîáùå, à ïðî êñàëàòàí - "äîêòîð" î÷åíü äàëåê âîîáùå îò ìåäèöèíû.
|
#3
|
||||
|
||||
@Â ýòî âðåìÿ áûëî ïðîâåäåíî 3 êóðñà èãëîóêàëûâàíèÿ, ýëåêòðîñòèìóëÿöèè, äåíîñ, ìàãíèò, ôîòîòåðàïèÿ, ìàññàæ. @
À ÷òî ëå÷èëè-òî? |
#4
|
|||
|
|||
|
#5
|
|||
|
|||
Èñïîëüçîâàíèå Êñàëàòàíà â âàøåì ñëó÷àå âîîáùå áåçîñíîâàòåëüíî! Ñîãëàñíà ñ êîëëåãàìè ÷òî ýòî ïîëíûé àóò. Ïðîãðåññèðîâàíèå ó âàøåãî ñûíà âîîáùå òî íà âåðõíåé ãðàíèöå íîðìû, ò.ê áûñòðûì ïðîãðåññèðîâàíèåì ìèîïèè êàê ïðàâèëî ñ÷èòàþò áîëåå 1,0 Ä â ãîä. È íóæíû áîëåå ïîäðîáíûå äàííûå äëà îöåíêè ñîñòîÿíèÿ ðåôðàêöèè è îñòðîòû çðåíèÿ âàøåãî ñûíà â äèíàìèêå (òî åñòü êàê ìèíèóì 2 ïîñëåäíèõ îñìîòðà). Ýôôåêòèâíîñòü ñêëåðîïëàñòèêè êàê ìåòîäà ïðèîñòàíàâëèâàþùåãî ïðîãðåññèðîâàíèå ìèîïèè íà ñåãîäíÿ øíèé äåíü íå äîêàçàíà, à çàðóáåæîì òàê è âîîáùå íå ïðèìåíÿåòñÿ. Îäíîé èç âåðîÿòíûõ ïðè÷èí óâåëè÷èåíèÿ ñòåïåíè ìèîïèè ó âàøåãî ñûíà ìîæåò áûòü ñíèæåíèå çàïàñà îòíîñèòåëüíîé àêêîìîäàöèè (ÇÀÎ).  òàêîì ñëó÷àå íóæíû áîëåå ñëàáûå î÷êè äëÿ ðàáîòû âáëèçè. Ýòîò ïàðàìåòð, êñòàòè, êðàéíå ðåäêî êòî ïðîâåðÿåò (çà èñêëþ÷åíèåì äåòñêèõ öåíòðîâ êîððåêöèè çðåíèÿ).Î÷êè -2,5 áûëè íàçàí÷åíû âàì äëÿ ïîñòîÿííîãî íîøåíèÿ? Êîððåêöèÿ áûëà ïîëíàÿ? Èëè îñòàâëÿëè íåïîëíóþ äëÿ òîãî ÷òîáû "ãëàç ðàáîòàë", êàê ëþáÿò ïî ñòàðèíêå äåëàòü íåêîòîðûå îôòàëüìîëîãè?
|
#6
|
||||
|
||||
Íàçâàòü ïðèìåíåíèå ãèïîòåíçèâíûõ êàïåëü ïîëíûì àóòîì íàçâàòü íåëüçÿ ïî ïðè÷èíå òîãî, ÷òî òåîðåòè÷åñêè óðîâåíü âíóòðèãëàçíîãî äàâëåíèÿ ìîæåò ñêàçûâàòüñÿ íà òåìïàõ ðîñòà ãëàçíîãî ÿáëîêà, ñîîòâåòñòâåííî è íà ïðîãðåññèðîâàíèè áëèçîðóêîñòè. Äðóãîå äåëî, íåò êà÷åñòâåííûõ êëèíè÷åñêèõ èñïûòàíèé äëÿ äàííîãî ãèïîòåòè÷åñêîãî ñïîñîáà ñäåðæèâàíèÿ áëèçîðóêîñòè.
Ïðèíèìàÿ âî âíèìàíèå îòñóòñòâèå íîðìàëüíîé äîêàçàòåëüíîé áàçû ýôôåêòèâíîñòè ãèïîòåíçèâíîé òåðàïèè â äåëå ñäåðæèâàíèÿ áëèçîðóêîñòè, íàëè÷èå ïîáî÷íûõ ýôôåêòîâ ïðè ïðèìåíåíèè êñàëàòàíà ó âçðîñëûõ, ïî÷òè ïîëíîå îòñóòñòâèå èññëåäîâàíèé ïðèìåíåíèÿ êñàëàòàíà èìåííî ó äåòåé, ñ÷èòàë áû íàçíà÷åíèå äàííîãî ïðåïàðàòà ðåá¸íêó ñ áëèçîðóêîñòüþ íåöåëåñîîáðàçíûì è íåêîððåêòíûì, ìÿãêî ãîâîðÿ. ÕÎÒß, ÅÑËÈ ÃÎÂÎÐÈÒÜ ÃÐÓÁÎ, ÒÎ, ÂÎÇÌÎÆÍÎ, ÝÒÎ ÏÎËÍÛÉ ÀÓÒ È ÅÑÒÜ. Âñïîìèíàåòñÿ àíåêäîò: "À ÷òî, êîììóíèçì ó÷¸íûå èëè ïîëèòèêè ïðèäóìàëè?.. Åñëè ó÷¸íûå, òî îíè õîòÿ áû íà êðîëèêàõ äëÿ íà÷àëà ïîïðîáîâàëè." |
#7
|
||||
|
||||
Îá àêóïóíêòóðå ñâåæåíüêîå:
Acupuncture for slowing the progression of myopia in children and adolescents. Wei ML, Liu JP, Li N, Liu M. Source Chinese Cochrane Centre, Chinese Evidence-Based Medicine Centre, West China Hospital, Sichuan University, No. 37, Guo Xue Xiang, Chengdu, Sichuan, China, 610041. Abstract BACKGROUND: Myopia (near-sightedness or short-sightedness) is one of the three commonly detected refractive (focusing) errors. Acupuncture is the stimulation of acupuncture points by various methods including needle insertion and acupressure. It is often used by traditional Chinese medicine practitioners to treat myopia in children. OBJECTIVES: To assess the effectiveness and safety of acupuncture in slowing the progression of myopia in children and adolescents. SEARCH STRATEGY: We searched CENTRAL (which contains the Cochrane Eyes and Vision Group Trials Register) (The Cochrane Library 2011, Issue 7), MEDLINE (January 1950 to July 2011), EMBASE (January 1980 to July 2011), the Allied and Complementary Medicine Database (AMED) (January 1985 to July 2011), Latin American and Caribbean Health Sciences Literature Database (LILACS) (January 1982 to July 2011), the metaRegister of Controlled Trials (mRCT) ([Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]), ClinicalTrials.gov ([Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]), the National Center for Complementary and Alternative Medicine (NCCAM) (The first issue to August 2010), the Chinese Biological Medicine Database (CBM) (1978 to April 2011), China National Knowledge Infrastructure (CNKI) (1994 to April 2011) and VIP (1989 to April 2011). There were no date or language restrictions in the electronic searches for trials. CENTRAL, MEDLINE, EMBASE, AMED, LILACS, mRCT and ClinicalTrials.gov were last searched on 9 July 2011. NCCAM was searched up to August 2010 and CBM, CNKI, and VIP were last searched on 6 April 2011. SELECTION CRITERIA: We included randomized controlled trials (RCTs) that included any type of acupuncture treatment for myopia in children and adolescents. DATA COLLECTION AND ANALYSIS: Two authors independently evaluated the search results according to the inclusion and exclusion criteria. Two authors extracted and assessed data independently. We contacted the study investigator for missing data. MAIN RESULTS: We included two RCTs conducted in Taiwan with a total of 131 participants. We did not perform a meta-analysis as the trials were assessing different outcomes. Neither trial met our pre-defined primary outcome criteria of myopia progression defined as one diopter mean change. Only one trial reported the changes of axial length without non-significant difference among groups and both trials reported that several children experienced mild pain during acupuncture stimulation. AUTHORS' CONCLUSIONS: Two trials are included in this review but no conclusions can be drawn for the benefit of co-acupressure for slowing progress of myopia in children. Further evidence in the form of RCTs are needed before any recommendations can be made for the use of acupuncture treatment in clinical use. These trials should compare acupuncture to placebo and have large sample sizes. Other types of acupuncture (such as auricular acupuncture) should be explored further as well as compliance with treatment for at least six months or longer. Axial length elongation of the eye should be investigated for at least one year. The potential to reduce/eliminate pain from acupuncture experienced by children should also be reviewed.Èç âûâîäîâ: Äîïîëíèòåëüíûå ðàíäîìèçèðîâàííûå êëèíè÷åñêèå èñïûòàíèÿ íåîáõîäèìû, ïðåæäå ÷åì äàâàòü êàêèå ëèáî ðåêîìåíäàöèè ïî ïðèìåíåíèþ àêóïóíêòóðû êàê ìåòîäà ëå÷åíèÿ. |
|
#8
|
|||
|
|||
ëåò 20 íàçàä âåðèëè â âîçìîæíîå âîçäåéñòâèå ñíèæåíèåì ÂÃÄ ïðè íàçíà÷åíèè â-áëîêàòîðîâ íà ïðîãðåññèðîâàíèå ìèîïèè. Îäíàêî, äàæå ñ ó÷åòîì "ýòîé âåðñèè", íàçíà÷åíèå êñàëàòàíà - ïðîñòàãëàíäèíà-ìåäèàòîðà âîñïàëåíèÿ ñ ìåõàíèçìîì îñíîâíîãî äåéñòâèÿ íà óâåîñêëåðàëüíûé îòòîê, - ïîëíûé àóò!
Êðîìå òîãî, êàê ìû çíàåì/äîãàäûâàåìñÿ - îñíîâíîé ìåõàíèçì â-áëîêàòîðîâ êàïåëü ñâîäèòñÿ ê ÓÌÅÍÜØÅÍÈÞ ïðîäóêöèè âîäÿíèñòîé âëàãè, ÷òî â íîðìàëüíîì è, òåì áîëåå, ìèîïè÷åñêîì ãëàçó ïðèâîäèò ê óõóäøåíèþ òðîôèêè è, â ðÿäå ñëó÷àåâ, - ïîãðåññèðîâàíèþ äèñòðîôè÷åñêèõ ïðîîöåññîâ. Íó, åñëè êòî ãîíèòñÿ çà äëèííûìè ðåñíèöàìè, - îôòàëüìîëîãè, ñ÷èòàþùèå ñëîâî "áðåä" ãðóáîñòüþ, - âïåðåä! íî íå äåòÿì! Ýòî íå áðåä - ýòî âàðâàðñòâî è ìíîæåñòâî äðóãèõ íåëåñòíûõ ñëîâ. |
#9
|
|||
|
|||
Ñïàñèáî áîëüøîå çà îòçûâû. Ìû æèâ¸ì â Îäåññå, ãäå åñü äâå áîëüøèå èçâåñòíûå ìåäèöèíñêèå êëèíèêè, ìû óæå êîíñóëüòèðîâàëèñü âåçäå. Äëÿ ìåíÿ îãðîìíàÿ íåîæèäàííîñòü óçíàòü, ÷òî ìåòîäèêà ëå÷åíèÿ áëèçîðóêîñòè ó íàñ òàêàÿ íåëåïàÿ. Î÷åíü îáèäíî, ÷òî ñòîëüêî âðåìåíè ìó÷àëà ðåá¸íêà ïîåçäêàìè íà ïðîöåäóðû.
Íåóæåëè íå ñóùåñòâóåò äåéñòâåííûõ ìåòîäîâ îñòàíîâêè ðîñòà áëèçîðóêîñè ó äåòåé? |
#10
|
|||
|
|||
ß î÷åíü íå õî÷ó íèêîãî îáèæàòü, ÷åñòíî, íî...
Èç òîãî ÷òî õîòÿ áû êàê-òî ìîæåò ïîäåéñòâîâàòü - íàçíà÷åíèå àòðîïèíà, ñâåæèé âîçäóõ è ôèç. íàãðóçêè è....ïîñëåäíèå âåÿíèÿ - îðòîïòèêà. Ïîñìîòðèòå ýòè òåìû, ìû îáñóæäàëè èõ áîëåå ïîäðîáíî íà ôîðóìå. |
#11
|
|||
|
|||
Ê ñîæàëåíèþ, äåéñòâèòåëüíî â Îäåññå åñòü "âðà÷è", êîòîðûå äàëåêè íå òîëüêî îò äîêàçàòåëüíîé, íî è îò ìåäèöèíû âîîáùå, à òîëüêî ïîëüçóþòñÿ èìåíåì ó÷ðåæäåíèé, â êîòîðûõ ðàáîòàþò è àâòîðèòåòîì ðåàëüíî ïðîôåññèîíàëüíûõ êîëëåã.
|
#12
|
|||
|
|||
ÿ î÷åíü ëþáëþ îäåññèòîâ è, ïîõîæå, îáñëåäîâàíèÿ è äèàãíîç - òî ïðàâèëüíûå, ýòî óæå õîðîøî. Íî âîò ëå÷åíèå - ñëåäñòâèå ïðîïàãàíäû ôèðì è ïð. äîêëàäîâ - ïîõîæå íà òî...
|
#13
|
|||
|
|||
Ïðîøëî ïîëãîäà, áëèçîðóêîñòü óâåëè÷èëàñü åù¸ íà 0,5 äï, òåïåðü îíà óæå -3,5.  î÷êàõ -2,5 ÷èòàåò 2-3 ñòðî÷êè â òàáëèöå. Ðåá¸íêó ïî÷òè 13 ëåò. Íàøà âðà÷è íàñòàèâàþò íà ñðî÷íîé ñêëåðîïëàñòèêå, ìû îòêàçàëèñü.
Õîòèì ñúåçäèòü â Êðûìñêèé öåíòð ïîçàíèìàòüñÿ íà èõ òðåíàæ¸ðàõ. Âðîäå áû ìîæíî àïïàðàòû ïðèîáðåñòè ó íèõ ïîòîì äëÿ åæåäíåâíûõ çàíÿòèé äîìà. Åñòü ëè íàäåæäà, ÷òî ýòî ïîìîæåò ïðèòîðìîçèòü ðîñò áëèçîðóêîñòè, èëè èíôîðìàöèÿ íà èõ ñàéòå - âñåãî ëèøü î÷åðåäíàÿ ðåêëàìà? |
#14
|
||||
|
||||
Ïðîãðåññèðîâàíèå óñòàíîâëåíî ïðè öèêëîïëåãèè? ×òî ìåøàåò ïîïðîáîâàòü äëèòåëüíóþ àòðîïèíèçàöèþ, à íå åõàòü â Êðûì "íà òðåíàæåðû", à òåì áîëåå ïðèîáðåòàòü èõ äîìîé?
|
#15
|
|||
|
|||
Öèòàòà:
Äëèòåëüíóþ àòðîïèíèçàöèþ ó íàñ íèêòî íå ïðåäëàãàåò, à ñàìà ÿ òàêîå ðåá¸íêó íàçíà÷èòü íå ìîãó. ÏÎäñêàæèòå, ïîæàëóéñòà, êóäà ìîæíî îáðàòèòñÿ, ÷òîáû íàçíà÷èëè ëå÷åíèå, îòëè÷íîå îò òîãî, ÷òî ïðåäëàãàþò â Îäåññå.  èíñòèòóòå Ôèëàòîâà íàì íàçíà÷àþò óïðàæíåíèÿ, êîòîðûå çàêëþ÷àþòñÿ â òîì, ÷òî ðåá¸íêó ìåíÿþò ñò¸êëûøêè è îí âñìàòðèâàåòñÿ â òàáëèöó. À â êëèíèêå ïðè ìåäèíå - ôèçèîòåðàïèþ, êîòîðàÿ íèêàê íå âëèÿåò íà ñêîðîñòü ðîñòà áëèçîðóêîñòè. ÍÀñòàèâàþò ëèáî íà êñàëàòàíå (ÿ òàê ïîíèìàþ, ÷òî ýòî ïðîâîäèòñÿ êàêîé-òî íåîôèöèàëüíûé ýêñïåðèìåíò, ò.ê. êàðòî÷êè ýòèõ äåòåé äåðæàò îòäåëüíî, íî íè îäíîãî ñëó÷àÿ ýôôåêòèâíîñòè íåò), ëèáî íà ñêëåðîïëàñòèêå, ïðè÷¸ì ñðî÷íîé, ïîêà ãëàç ðàñò¸ò. |